SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GT Biopharma, Inc. (GTBP) Reports $3.5M Q3 Net Loss

GT Biopharma reported Q3 2026 net loss of approximately $3.5M, versus net income of $8.3M in Q3 2025; the prior-period result included $11.4M of non-cash income from a fair-value change. Cash of approximately $10M is expected to fund operations into Q3 2027.Material DetailsContext by AI AnalystThis…

GTBP

Related stories